Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
04 2020
Historique:
received: 27 08 2019
revised: 02 02 2020
accepted: 16 02 2020
pubmed: 24 2 2020
medline: 27 10 2020
entrez: 24 2 2020
Statut: ppublish

Résumé

Juvenile papillomatosis (JP), the so-called Swiss cheese disease, is a rare benign breast disease of young adults. An association (up to 28%) with breast cancer within the family of affected patients has been reported. A multinodular cystic breast mass lesion and calcifications characterizes JP in imaging studies. The histological picture is diverse and comprises multiple intraductal papillomas, usual ductal hyperplasia, ductectasias, perifocal sclerosing adenosis, and calcification. Patients with complete excision of JP lesions have an excellent follow-up; breast cancer develops only on a very low subset of patients. Molecular background of JP has not been investigated until now. In this study, we addressed mutational analysis of JP cases and correlated these results with follow-up and family history in context with a comprehensive review of the JP literature. We identified 13 cases fulfilling the criteria of JP. All patients were women with a median age of 38 years (26-50 years). Follow-up information was available for 11 of 13 patients. Sufficient paraffin-embedded tissue and good DNA quality for next-generation sequencing (NGS) was available for 10 patients. Paraffin blocks were microdissected in the area of intraductal proliferative disease; the tissue cores underwent NGS analysis using the Oncomine Comprehensive Panel. In 5 of 10 patients, we found PIK3CA mutations; in 2 of 10 patients, we found AKT1 mutations in known hot spot regions. Further mutations in MET, FGFR3, PTEN, ATM, NF1, and GNAS genes were detected in individual patients. Some of these mutations were present at high allele frequencies suggesting germ line mutations. Two of 3 patients with positive family history had PIK3CA mutation; one patient with positive family history had an AKT1 mutation. One patient who subsequently developed invasive ductal carcinoma in the contralateral breast possibly had a germ line ATM mutation. Our results confirm hot spot mutations in PIK3CA and AKT1 genes in JP associated with positive family history for breast cancer, although these mutations are not specific for JP. The genetic link between JP, positive family history, and subsequent risk of breast cancer needs to be analyzed in further studies.

Identifiants

pubmed: 32088208
pii: S0046-8177(20)30020-4
doi: 10.1016/j.humpath.2020.02.002
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Class I Phosphatidylinositol 3-Kinases EC 2.7.1.137
PIK3CA protein, human EC 2.7.1.137
AKT1 protein, human EC 2.7.11.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

64-73

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Carole Guillet (C)

Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Switzerland; Clinic of Dermatology, University Hospital Zurich, 8091, Switzerland.

Markus Rechsteiner (M)

Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Switzerland.

Elisa Bellini (E)

Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Switzerland.

Matthias Choschzick (M)

Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Switzerland.

Linda Moskovszky (L)

Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Switzerland.

Konstantin Dedes (K)

Clinic of Gynecology, University Hospital Zurich, 8091, Switzerland.

Bärbel Papassotiropoulos (B)

Breast Center Seefeld Zurich, 8008, Switzerland.

Zsuzsanna Varga (Z)

Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Switzerland. Electronic address: zsuzsanna.varga@usz.ch.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH